USD10
CERS Shares
About CerusCerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety, and generates revenue from the same.
USD10
CERS Shares
About CerusCerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety, and generates revenue from the same.
Stats
TRADING WINDOW
Closed
OPENS AT
Mar 26 at 1:30 PM GMT+0
MARKET CAP
$351.67M
OPEN PRICE
$1.81
LOW (1Y)
$1.12
HIGH (1Y)
$2.96
LOW (24H)
$1.80
HIGH (24H)
$1.91
VOLUME (24H)
$870.11K
79.42%
Price history
Time | Price | Change |
|---|---|---|
Today | $1.81 | |
1 Day | $1.84 | |
1 Week | $1.76 | |
1 Month | $2.60 | |
1 Year | $1.44 |
A new era of Coinbase has begun
The future of money is here. Be one of the first to get access and try new features the moment they’re available.
Create an account now